UnitedHealth Group Updates Business Outlook Ahead of Investor Conference

Rhea-AI Summary

UnitedHealth Group (NYSE: UNH) announced its financial guidance ahead of the annual Investor Conference set for November 30, starting at 8 a.m. ET. For 2021, the company forecasts revenues of approximately $287 billion, with net earnings between $17.80 and $17.95 per share. The 2022 outlook suggests revenues between $317 billion and $320 billion, net earnings of $20.20 to $20.70 per share, and adjusted net earnings of $21.10 to $21.60 per share. Expected cash flows from operations for 2022 range from $23 billion to $24 billion.

Positive

• 2021 revenue forecast of approximately $287 billion.
• 2022 revenue outlook between $317 billion and $320 billion.
• 2022 net earnings projected at $20.20 to $20.70 per share.

Negative

• Risks associated with public health crises, including COVID-19.
• Potential impacts from changes in healthcare laws and regulations.

MINNETONKA, Minn.--(BUSINESS WIRE)-- UnitedHealth Group (NYSE: UNH) issued financial guidance ahead of its annual Investor Conference which takes place on November 30, beginning at 8 a.m. ET.

UnitedHealth Group revenues for 2021 are expected to be approximately $287 billion, with net earnings of $17.80 to $17.95 per share and adjusted net earnings of $18.75 to $18.90 per share. Adjusted net earnings only excludes the after-tax non-cash amortization expense pertaining to acquisition-related intangible assets.

UnitedHealth Group will also introduce its 2022 outlook, which includes revenues of $317 billion to $320 billion, net earnings of $20.20 to $20.70 per share, and adjusted net earnings of $21.10 to $21.60 per share. Cash flows from operations are expected to range from $23 billion to $24 billion in 2022.

The Company will stream the presentation and management question-and-answer portion of this meeting on its Investor Relations page at www.unitedhealthgroup.com. Meeting materials and a replay of the conference will be available on the Investor Relations page.

About UnitedHealth Group

UnitedHealth Group (NYSE: UNH) is a diversified health care company dedicated to helping people live healthier lives and helping make the health system work better for everyone. UnitedHealth Group offers a broad spectrum of products and services through two distinct platforms: UnitedHealthcare, which provides health care coverage and benefits services; and Optum, which provides information and technology-enabled health services. For more information, visit UnitedHealth Group at www.unitedhealthgroup.com or follow @UnitedHealthGrp on Twitter.

Non-GAAP Financial Information

This news release presents non-GAAP financial information provided as a complement to the results provided in accordance with accounting principles generally accepted in the United States of America (“GAAP”). Adjusted net earnings exclude amortization expense of approximately $1.25 and $1.20 per share and the related tax impacts of $0.30 per share for years ending December 31, 2021 and 2022, respectively, pertaining to acquisition-related intangible assets.

Forward-Looking Statements

The statements, estimates, projections, guidance or outlook contained in this document include “forward-looking” statements which are intended to take advantage of the “safe harbor” provisions of the federal securities law. The words “believe,” “expect,” “intend,” “estimate,” “anticipate,” “forecast,” “outlook,” “plan,” “project,” “should” and similar expressions identify forward-looking statements. These statements may contain information about financial prospects, economic conditions and trends and involve risks and uncertainties. Actual results could differ materially from those that management expects, depending on the outcome of certain factors including: risks associated with public health crises, large-scale medical emergencies and pandemics, such as the COVID-19 pandemic; our ability to effectively estimate, price for and manage medical costs; new or changes in existing health care laws or regulations, or their enforcement or application; the DOJ’s legal action relating to the risk adjustment submission matter; our ability to maintain and achieve improvement in quality scores impacting revenue; reductions in revenue or delays to cash flows received under government programs; changes in Medicare, the CMS star ratings program or the application of risk adjustment data validation audits; failure to maintain effective and efficient information systems or if our technology products do not operate as intended; cyberattacks, other privacy/data security incidents, or our failure to comply with related regulations; risks and uncertainties associated with the pharmacy benefits management industry; competitive pressures; changes in or challenges to our public sector contract awards; our ability to contract on competitive terms with physicians, hospitals and other service providers; failure to attract, develop, retain, and manage the succession of key employees and executives; the impact of potential changes in tax laws and regulations (including any increase in the U.S. income tax rate applicable to corporations); failure to achieve targeted operating cost productivity improvements; increases in costs and other liabilities associated with litigation, government investigations, audits or reviews; failure to manage successfully our strategic alliances or complete or receive anticipated benefits of strategic transactions; fluctuations in foreign currency exchange rates; downgrades in our credit ratings; our investment portfolio performance; impairment of our goodwill and intangible assets; and our ability to obtain sufficient funds from our regulated subsidiaries or from external financings to fund our obligations, maintain our debt to total capital ratio at targeted levels, maintain our quarterly dividend payment cycle, or continue repurchasing shares of our common stock. This above list is not exhaustive. We discuss these matters, and certain risks that may affect our business operations, financial condition and results of operations more fully in our filings with the SEC, including our reports on Forms 10-K, 10-Q and 8-K. By their nature, forward-looking statements are not guarantees of future performance or results and are subject to risks, uncertainties and assumptions that are difficult to predict or quantify. Actual results may vary materially from expectations expressed or implied in this document or any of our prior communications. You should not place undue reliance on forward-looking statements, which speak only as of the date they are made. We do not undertake to update or revise any forward-looking statements, except as required by law.

View source version on businesswire.com: https://www.businesswire.com/news/home/20211129005670/en/

Brett Manderfeld

Brett_Manderfeld@uhg.com

952-936-7216

Media:

Matt Stearns

Matt.Stearns@uhg.com

202-276-0085

Source: UnitedHealth Group

FAQ

What is UnitedHealth Group's revenue forecast for 2021?

UnitedHealth Group expects revenues of approximately $287 billion for 2021.

What are the projected net earnings per share for UnitedHealth Group in 2022?

The projected net earnings per share for 2022 are between $20.20 and $20.70.

When is UnitedHealth Group's annual Investor Conference?

The annual Investor Conference is scheduled for November 30 at 8 a.m. ET.

What is the expected cash flow from operations for UnitedHealth Group in 2022?

Cash flows from operations for 2022 are expected to be between $23 billion and $24 billion.